Peng Wang, MD PhD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (NCT03343977) | Peng Wang, MD PhD | 2018-02-14 |
Track Peng Wang, MD PhD automatically
Every clearance here is in the API, with alerts when new ones post.